Opposite effects of nuclear factor-jB (NF-jB) on neuron survival rely on activation of diverse NF-jB factors. While p65 is necessary for glutamate-induced cell death, c-Rel mediates prosurvival effects of interleukin-1b. However, it is unknown whether activation of c-Rel-dependent pathways reduces neuron vulnerability to amyloid-b (Ab), a peptide implicated in Alzheimer's disease pathogenesis. We show that neuroprotection elicited by activation of metabotropic glutamate receptors type 5 (mGlu5) against Ab toxicity depends on cRel activation. Ab peptide induced NF-jB factors p50 and p65. The mGlu5 agonists activated c-Rel, besides p50 and p65, and the expression of manganese superoxide dismutase (MnSOD) and Bcl-X L . Targeting c-Rel expression by RNA interference suppressed the induction of both antiapoptotic genes. Targeting c-Rel or Bcl-X L prevented the prosurvival effect of mGlu5 agonists. Conversely, c-Rel overexpression or TATBcl-X L addition rescued neurons from Ab toxicity. These data demonstrate that mGlu5 receptor activation promotes a c-Reldependent antiapoptotic pathway responsible for neuroprotection against Ab peptide.
Introduction
Nuclear factors-kB (NF-kB) are widely expressed in developing and mature central nervous system, 1 where they regulate the adaptive responses to environmental factors stimulusdependently. 2, 3 The NF-kB family of dimeric transcription factors include p50, p52, p65 or RelA, RelB and c-Rel proteins, which use the Rel homology domain for dimerization and DNA binding. 4 In resting cells, NF-kB factors interact with inhibitory IkB proteins. Cellular stimulation results in phosphorylation, ubiquitination and degradation of IkB, allowing NF-kB dimers to translocate to the nucleus where they regulate transcriptional function. Besides regulating long-term changes to neuronal function in response to synaptic transmission, 5, 6 NF-kB factors participate in pathological events associated with neurodegeneration.
2,7-9 Increased NF-kB activation has been observed in neurons exposed to trauma and ischemia, [9] [10] [11] [12] as well as in the brains of patients with Parkinson's or Alzheimer's disease. [13] [14] [15] However, accumulating evidence has pointed to NF-kB as a survival determinant for neurons. [16] [17] [18] It has been shown that NF-kB mediates neuroprotection elicited by tumor necrosis factor in hippocampal cells 19, 20 and promotes neuron resistance to excitotoxicity 21, 22 and amyloid b (Ab)-induced apoptosis. 23 We hypothesized that the opposite regulation of neuron survival by NF-kB in response to proapoptotic or antiapoptotic stimuli might depend on the activation of distinct combinations of subunits resulting in transcriptional regulation of diverse subsets of genes dictating the cell response. [24] [25] [26] By studying glutamate and interleukin-1b (IL-1b), we showed that the neurotoxic effect produced by N-methyl-D-aspartate receptor activation in cerebellar granule cells and hippocampal slices was associated with activation of NF-kB dimers composed of p50 and p65 proteins, whereas neuroprotection elicited by IL1b correlated with activation of c-Rel-containing dimers. Targeting p65 expression with antisense oligodeoxynucleotides prevented glutamate-mediated cell death, while targeting c-Rel abolished IL-1b neuroprotection. 27 Our present study sheds light on the prosurvival role of c-Rel factor in neuronal cells and shows that activation of the c-Reldependent antiapoptotic pathway reduces neuronal vulnerability to Ab 1-40 peptide. We demonstrate that neuroprotective activity of agonists at metabotropic glutamate receptor type 5 (mGlu5) against Ab-mediated apoptosis relies on c-Rel activation. The post-transcriptional silencing of c-Rel gene by RNA interference technique, as its deletion in c-Rel as manganese superoxide dismutase (MnSOD) and Bcl-X L expression. Conversely, c-Rel overexpression, or the application of TAT-Bcl-X L protein, reduced Ab-mediated apoptosis.
Results
Activation of mGlu5 receptors prevented Ab toxicity and induced NF-jB activation in mouse cortical neurons and in human SK-N-SH cells
The treatment of primary cultures of mouse cortical neurons with different concentrations of 3HPG, a group I mGlu receptor agonist, prevented neuronal cell death induced by 48 h exposure to 5 mM Ab. By using MTT reduction as an index of neuron viability we found about 55% of cell survival in Abtreated cells and more than 90% in cultures co-exposed to 50 mM 3HPG (Figure 1b) . The data obtained by MTT reduction were very similar to those found by counting TUNEL positive cells ( Figure 1a ). The TUNEL staining of neuronal cells showed a large number of nuclei displaying chromatin fragmentation in Ab-treated cultures (4673% of total cells), but nearly no staining in cultures co-exposed to 3HPG (572% of total cells), as in control culture (473% of total cells). The neuroprotective effect of 3HPG was prevented by the selective mGlu5 receptor antagonist MPEP used at 5 mM concentration, and was reproduced by the selective mGlu5 receptor agonist CHPG at 1 mM concentration (Figure 3b, d ). These data indicated that mGlu5 subtype of mGlu receptors expressed in mouse cortical neurons 28 is mainly responsible for the neuroprotection elicited by 3HPG against Ab toxicity. To verify this phenomenon in another neuronal model, we used SK-N-SK cells differentiated by retinoic acid treatment. We found that neuronal SK-N-SH cells, besides expressing functional N-methyl-D-Aspartate receptors, 29 expressed mGlu1 and mGlu5 receptors. The RT-PCR analysis revealed the expression of both mGlu1 and mGlu5 receptor mRNAs in SK-N-SH cells, when compared to human thalamus templates (Figure 1c) . The immunoblot analysis of total cell extracts confirmed the presence of the receptor proteins (Figure 1d ). The application of 3HPG at 50 mM concentration prevented the release of cytochrome c into the cytosol (Figure 1e ) as well as the toxic effect produced by 24 h exposure to Ab peptide ( Figure 1f ). The neuroprotective response of 3HPG was blocked by MPEP, confirming that mGlu5 receptor signalling had a role in modulating the cell vulnerability to Ab peptide in different types of neuronal cells. No modification of cell survival was produced by MPEP alone in the two neuronal cultures (Figure 1b, f) . Then, we investigated the effect produced by mGlu5 receptor stimulation on the activity of NF-kB transcription factor. An ELISA-based analysis of DNA-binding interactions for the different NF-kB factors was performed in nuclear extracts prepared from cortical neurons (Figure 2b ). By this procedure we obtained results similar to those found by EMSA and super shift analysis (Figure 2a) . A 20-min application of 50 mM 3HPG or 1 mM CHPG to cortical cells activated NF-kB, as shown by the nuclear translocation of NF-kB factors p50, p65 and c-Rel (Figure 2b) . Besides, in line with previous evidence, 15, 30, 31 20-min application of the Ab peptide induced NF-kB, but restricted to p50 and p65 subunits. An ELISAbased assay specific for human cells confirmed that both 3HPG and CHPG application to SK-N-SH neurons activated p50, p65 and c-Rel. No activation of RelB or p52 factors was detected (Figure 2c ). To elucidate the specific composition of NF-kB complexes, we carried out co-immunoprecipitation studies. Using antibodies against p50, p65 and c-Rel, we identified the p50/p65, p50/c-Rel and p65/c-Rel dimers in nuclear extracts from unstimulated cells (Figure 2d ). Control antibodies to IgG alone were unable to immunoprecipitate any NF-kB proteins. The CHPG treatment increased the nuclear amount of the c-Rel-containing complexes p50/c-Rel and p65/ c-Rel, while it left unchanged the nuclear content of p50/p65. Although this approach did not allow us to detect the activation of p50/p50 homodimer, it could be excluded by the lack of a lower band totally supershifted by p50 antibody in the EMSA analysis of NF-kB-DNA complexes. These results indicated that while Ab peptide activates dimers of p50 and p65 subunits, the mGlu5 receptor signalling leads to selective activation the NF-kB dimers p50/c-Rel and p65/c-Rel. (Figure 3a) . The c-Rel siRNA did not decrease the cellular amounts of p50, p65 or b-tubulin, indicating the specificity of cRel silencing. Indeed, the amounts of p50 and p65 appeared slightly increased in c-Rel silenced neurons, suggesting that their expression could compensate the lack of c-Rel in siRNAtreated cells. The siRNA treatment did not affect per se the neuron viability. At 48 h after application of siRNA, cells were exposed for an additional 48 h to Ab with or without mGlu5 receptor agonists. As shown in Figure 3b , the c-Rel targeted cells were vulnerable to Ab toxicity, as were cells treated with non-siRNA used as a negative control. Conversely, the c-Rel targeted cells became totally resistant to mGlu5 receptormediated neuroprotection. A higher vulnerability trend was observed in c-Rel silenced neurons co-exposed to Ab and 3HPG or CHPG. Parallel experiments were carried out in primary cultures of cortical neurons prepared from c-Rel
embryos ( Figure 3c ). As reported in Figure 3d , the Abmediated toxicity was preserved in c-Rel À/À cells, while the neuroprotective activity of mGlu5 receptor agonists was completely lost. These results support the observation that c-Rel factor is dispensable for Ab toxicity, but also absolutely necessary for mGlu5 receptor-mediated neuroprotection.
Overexpression of c-Rel reduced SK-N-SH cell vulnerability to Ab exposure 
CHPG induced Bcl-X L and MnSOD expression in SK-N-SH cells by induction of c-Rel
Bcl-X L and MnSOD are two prosurvival genes under the transcriptional control of NF-kB c-Rel factor in non-neuronal cells. [33] [34] [35] To demonstrate the participation of c-Rel in neuroprotection elicited by mGlu5 receptor activation, we investigated the effect of CHPG on MnSOD and Bcl-X L expression in neuronal cells pretreated with control nonsiRNA or c-Rel-siRNA. As shown in Figure 5a , the RT-PCR analysis revealed increased amounts of both MnSOD and Bcl-X L mRNAs in SK-N-SH cells exposed for 1 or 4 h to 1 mM CHPG ( Figure 5a ). Accordingly, the relative protein contents appeared increased 4 h after CHPG application ( Figure 5c ). Treatment with c-Rel-siRNA efficiently downregulated c-Rel expression ( Figure 5c ) and prevented the increase of both MnSOD and Bcl-X L by CHPG. A relative estimate of PCR products was carried out by evaluating the ratio between MnSOD or Bcl-X L and corresponding b-actin bands for each template ( Figure 5b ). Relative variations in protein amounts were measured as ratio between MnSOD or Bcl-X L bands and corresponding b-tubulin (Figure 5d ).
To verify the direct prosurvival role for at least one of these proteins on Ab-mediated cell death, we investigated the effect of TAT-Bcl-X L obtained by the fusion of the TAT protein transduction domain with the antiapoptotic Bcl-X L protein. 36 As shown in Figure 6a , the treatment with TAT-Bcl-X L at concentrations ranging from 100 to 300 nM completely rescued SK-N-SH cells from Ab neurotoxicity. Conversely, no protection against the Ab peptide was found in cells pretreated with a control TAT-GFP protein. Finally, to confirm the participation of Bcl-X L in the CHPG-mediated neuroprotection, we silenced the Bcl-X L expression in SK-N-SH neuronal cells by using a specific Bcl-X L siRNA. 37 The siRNA application reduced the protein content of Bcl-X L after 24 and 48 h (Figure 6b 
Discussion
Our data show that stimulation of mGlu5 receptors rescues neuronal cells from Ab-induced apoptosis. This effect requires activation of NF-kB transcription factor c-Rel and involves Bcl-X L and MnSOD induction.
Though the mechanisms underlying neurodegeneration in Alzheimer's disease remain unclear, a growing body of evidence implicates Ab in a pivotal role. 38, 39 A matter of controversy is whether the pathological cascade is initiated by accumulation of Ab in the extracellular space or by its intraneuronal generation. However, demonstration that wildtype neuronal tissue, when grafted into brain of APPtransgenic mice, also develops amyloid deposits and signs of neurodegeneration, 40 implicates the pathological contribution of extracellular Ab. A lot of evidence has proved the proapoptotic effect of the two main constituents of amyloid plaques, Ab 1-40 and Ab 1-42, in cultured neurons, [41] [42] [43] [44] [45] and their capability to induce accumulation of intracellular Ab. 46, 47 Although Ab 1-42 is considered the form initially deposited in diffuse plaques, the subsequent deposition of Ab 1-40 characterizes the formation of fibril-rich neuritic plaques with surrounding cytopathology. 38 For our study we used two different cell-based models of Ab-mediated toxicity, the primary cultures of mouse cortical cells and differentiated human SK-N-SH cells. In both neuronal cell types, activation of mGlu5 receptors prevented the cell loss produced by exposure to the Ab peptide. The precise role of group I mGlu receptors, including mGlu1 and mGlu5 subtypes, in regulating neuronal cell death is still debated. Most studies, addressed to evaluating poorly selective group I receptor ligands in models of excitotoxic or ischemia-induced injury, produced conflicting results. 48 The recent availability of more selective compounds has generated evidence suggesting that activation of mGlu1, but not mGlu5, is likely to play a major role in neurodegeneration secondary to brain ischemia. 49 The role of mGlu5 receptors is less clear, possibly because we lack mGlu5 agonists suitable for in vivo studies and most mGlu5 antagonists were found to block NMDA receptors, at high concentrations. [50] [51] [52] [53] By means of either pharmacological blockers or strategies targeting the receptor expression, it was shown that endogenous activation of mGlu5 receptors elicits antiapoptotic effect and sustains neuronal survival during early brain development. 54, 55 However, endogenous stimulation of mGlu5 receptors also contributes to neurotoxicity induced by the Ab 25-35 soluble fragment in cultured neurons 56 and amplifies nigro-striatal damage induced by methamphetamine or MPTP. 57, 58 More homogeneous but opposite evidence rise from studies investigating the effects of exogenous stimulation of mGlu5 receptors by selective agonists. It was shown that CHPG is neuroprotective in a rat model of cerebral ischemia when administered intraventricularly. 52 Activation of mGlu5 receptors protects neurons from oxidative stress, 59 as well as from neurotoxicity mediated by glutamate and by a variety of proapoptotic agents [60] [61] [62] including the Ab peptide. 63 It can be argued that, while endogenous stimulation of mGlu5 receptors, possibly associated with the activation of other glutamate receptor subtypes, is detrimental, selective exogenous stimulation of mGlu5 by pharmacological agonists leads to neuroprotection. This is in line with studies indicating that under sustained activation, the function of group I metabotropic receptors in the control of glutamate transmission and cell death can switch from a facilitating to an inhibiting mode. [64] [65] [66] [67] Transient stimulation of receptors can exacerbate neuron vulnerability. Tonic stimulation of receptors induces the desensitization of the facilitatory activity, switching the receptor function to the inhibitory activity and neuroprotection. Although not completely elucidated, the signalling pathway 65 We have here demonstrated that neuroprotection elicited by mGlu5 agonists was associated with activation of NF-kB factor c-Rel. In line with our previous evidence that peculiar composition of NF-kB dimers may contribute to establish neuronal cell fate in response to environmental stimuli, 27 and according to Akama et al., 68 we found that the neurotoxic Ab peptide activated only p50 and p65 subunits. Prevention of p50/p65 translocation, by a decoy oligonucleotide containing the kB regulatory sequence, prevented the Ab toxicity (data not shown). Conversely, by co-immunoprecipitation studies we demonstrated that the mGlu5 agonists activated p50/c-Rel and p65/c-Rel dimers. The activation of c-Rel-containing dimers was an absolute requirement for prosurvival effect elicited by mGlu5 receptor agonists. This was demonstrated by targeting c-Rel expression through either RNA interference or gene knockout techniques. Both conditions completely suppressed the prosurvival effect of mGlu5 agonists, while they did not affect the Ab-induced cell death. The involvement of c-Rel activation in NF-kB-preserved cell survival was further confirmed by overexpressing c-Rel in cultured neurons. The overexpression of c-Rel reproduced the neuroprotective effect of mGlu5 agonists in SK-N-SH cells, as previously found for the antiapoptotic response of nerve growth factor in sympathetic neurons 17, 69 or insulin-like growth factor-1 in cerebellar granule cells. 70 Consistent with our evidence, Movsesyan et al., 63 recently showed that mGlu5 receptor activation prevents the Abmediated apoptosis in rat cortical cells and reduces cytochrome c translocation, caspase-3 activation and apoptosisinducing factor release. We have here demonstrated that neuroprotection by mGlu5 agonists was associated with increased expression of the antioxidant enzyme MnSOD and the antiapoptotic protein Bcl-X L . MnSOD is a mitochondrial protein that catalyzes the dismutation of the anion superoxide radical to oxygen and hydrogen peroxide, a mechanism that may be responsible for cell resistance to apoptogenic burst of reactive oxygen species produced under Ab exposure. 30, 71 Neuronal cells overexpressing MnSOD exhibit nearly complete resistance to apoptosis induced by Ab. 71, 72 Bcl-X L is a bcl-x gene product generated, together with Bcl-X S , by alternative splicing of bcl-x transcript. 73 It is generally accepted that Bcl-X L preserves cell survival by controlling mitochondrial membrane ion permeability and cytochrome c release. 74 Additionally, it acts downstream of cytochrome c release through binding to the apoptosis protease-activating factor-1 that prevents procaspase-9 and subsequent caspase-3 activation. 75 Both MnSOD and Bcl-X L are expressed in neuronal tissues where their relative expression level can determine cell commitment to apoptosis. 19, 76, 77 We found that the intracellular increase of Bcl-X L , through exogenous application of a fusion protein of Bcl-X L with TAT protein transduction domain, 36 completely prevented the Ab-mediated cell death, as already reported for staurosporine-, glutamate-or ischemia-induced apoptosis. 78, 79 Both MnSOD and Bcl-X L genes were shown to be transcriptional targets of c-Rel [33] [34] [35] in non-neuronal cells. Though the transcriptional regulation of Bcl-X L and MnSOD by c-Rel has never been investigated in neurons, the p50/c-Rel dimers were found to bind to bcl-x gene promoter during brain ischemia. The p50/cRel activation appeared to be areaspecific and correlated with increased Bcl-X L expression and higher neuronal resistance to hypoxic insult. 80 Indeed, we found that the silencing of c-Rel abolished the increases of both MnSOD and Bcl-X L induced by CHPG. Besides, the silencing of Bcl-X L suppressed the neuroprotective activity of CHPG. These results give compelling evidence about the primary role of c-Rel in the antiapoptotic program activated by CHPG, which includes the expression of Bcl-X L and MnSOD.
The evidence that c-Rel-containing dimers are required for neuroprotection and induction of antiapoptotic genes is in line with the view that specific combination of NF-kB subunits within the NF-kB complex is responsible for activating specific subsets of genes. 24, 26 Though, an additional level of regulation of NF-kB-target genes, which may involve post-translational modification of nuclear NF-kB subunits and proteinprotein interaction with other promoter-bound factors, has recently emerged. 26 As recently reviewed, 81 both phosphorylation and acetylation of NF-kB factors are required to generate a fully active NF-kB complex. Phosphorylation of p65 has been found to promote the recruitment of the transcriptional coactivators, p300/CPB (CREB binding protein) and p300/CPB-associated factor, which, in turn, acetylate both p65 and histones surrounding the promoter of NFkB-target genes. It results in chromatin remodelling and increased transcriptional response. Likewise, phosphorylation of c-Rel is necessary for NF-kB-mediated transactivation and modulation of cell apoptosis in response to tumor necrosis factor-a. 82 It can be inferred that post-translational modifications, together with cooperation with other transcription factors, may integrate the signalling cascades activated by extracellular stimuli, to provide specificity and versatility in the regulation of genes and cellular responses by distinct NF-kB factors.
The specific role of c-Rel in neuronal pathophysiology emerges from our data and from a recent study dealing with molecular mechanisms of memory formation. Through a bioinformatics analysis and the use of c-Rel À/À mice, it was shown that c-Rel-mediated gene transcription is specifically required for the consolidation of long-term memory in the hippocampus. 6 Thus, clarifying the signalling cascade responsible for c-Rel activation, or for post-translational modifications implicated in the interaction of c-Rel with the transcriptional machinery in the brain, will unravel new potential targets for pharmacological treatment of neurodegenerative diseases and memory dysfunction.
Materials and Methods

Cell culture
Primary cultures of mouse cortical neurons
Fifteen-day embryonic mice were taken with cesarean section from anesthetized pregnant dams. C57/BL6 mice were purchased from Charles River, Italia, and c-Rel À/À mice (background strain C57/BL6) were provided by H-C Liou. 83 Cerebral cortices were isolated and dissociated by manual dispersion with a fire-polished Pasteur pipette. Cells were plated at a density of 1.5 Â 10 5 cells/cm 2 , in 8 cm 2 culture dishes (NUNC) for Western blot, EMSA and ELISA analyses, and in 2 cm 2 tissue culture c-Rel-mediated neuroprotection M Pizzi et al dishes for viability studies. Culture dishes were coated with 10 mg/ml poly-L-lysine. The cells were plated in Neurobasal medium (Invitrogen Corporation) supplemented with 2% B27 (Invitrogen Corporation), 0.5 mM L-glutamine and 50 U/ml penicillin/streptomicin (Invitrogen Corporation). At 3 days after plating, 50% of the medium was changed with fresh medium and subsequently 50% of the medium was changed twice a week, until 11 days in vitro.
SK-N-SH cell culture
The human SK-N-SH neuroblastoma cell line was purchased from American Type Culture Collection (Rockville, MD, USA) and cultured in DMEM as previously described. 29 Cells were plated at a density of 25 Â 10 3 /cm 2 in 8 cm 2 dishes (NUNC) and neuronally differentiated by addition of 50 mM RA for 12-15 days.
Beta-amyloid toxicity
Soluble Ab 1-40 (Bachem, Switzerland) was dissolved in water to a final concentration of 2.5 mM, divided into aliquots and frozen. Before being used it was left to aggregate for a week, at 371C. For our experiments, 11 DIV mouse cortical neurons or differentiated SK-N-SH cells were preincubated at 371C for 5 min with the following ligands for mGlu receptors (Tocris, UK), (S)-3-hydroxy-phenyl-glycine (3HPG) or (R,S)-2-chloro-5-hydroxyphenylglycine (CHPG). When present, 2-methyl-6-phenylethynyl-pyridine (MPEP) was co-administered. TAT-Bcl-X L and TAT-GFP (green fluorescent protein), 36 kindly provided by Dr. S Cheng (Weill Medical College of Cornell University, New York, USA), were dissolved in serumfree medium and added to SK-N-SH cells during Ab exposure. The Ab 1-40 was then added at a concentration of 5 mM and incubation was carried out for 48 h in a Neurobasal/B27 medium for cortical neurons, or for 24 h in a serum-free medium for SK-N-SH cells. At the end of these periods, cell viability was determined by various techniques. The conversion of tetrazolium bromide (MTT) (Sigma) to purple formazan was measured. The reaction product obtained after 1 h of cell incubation with 0.5 mg/ml MTT was analyzed spectrophotometrically at 540 nm with an automated microplate reader. MTT is a water-soluble tetrazolium salt that is converted to insoluble purple formazan by dehydrogenase enzymes. As active mitochondrial dehydrogenases of living cells, but not of dead cells, cause MTT conversion, this method is used to measure cell viability according to Hansen et al. 84 Terminal deoxynucleotidyltransferase-mediated dUTP nick end labelling (TUNEL) was performed using the kit purchased by Roche Molecular Biochemicals according to the manufacturer's instructions. The TUNEL positive cells were counted in eight different fields for each well taken from experiments that were run in triplicate. The ratio between TUNEL positive cells and Hoechst labelled neurons was calculated. The release of cytochrome c was measured according to Movsesyan et al., 63 by immunoblot analysis of cytosolic extracts.
Transfection with expression plasmids
Transfection of differentiated SK-N-SH cells was carried out according to the manufacturer's instructions with LipofectAMINE 2000 Reagent (LF 2000, Invitrogen Corporation). The day before transfection cultures were incubated with normal growth medium containing serum and without antibiotics. Cells were transfected with expression plasmids encoding cRel (pSG-cRel), or with the expression vector pSG5 85 as a negative control. For each cell well, 1 mg of DNA was diluted into 50 ml of Opti-MEM (Invitrogen Corporation) and 3 ml of LF 2000 Reagent into 50 ml of Opti-MEM. The two solutions were mixed and incubated for 20 min at room temperature to form the transfection complex. After washing the cells with serum-free medium, the transfection complex was added to the cells at a final volume of 1 ml in DMEM without serum and antibiotics. Cells were incubated at 371C under an atmosphere of 5% CO 2 , 95% air for 24 h, before undergoing the experiment with the Ab peptide.
Transfection with siRNA 0 . The siRNAs were dissolved in buffer (100 mM potassium acetate, 30 mM HEPES-potassium hydroxide, 2 mM magnesium acetate, pH 7.4) to a final concentration of 20 mM, heated at 901C for 60 s and incubated at 371C for 60 min before use, to disrupt any higher aggregates forming during the synthesis. Cell transfection was carried out as follows: for every 2 cm 2 dishes, c-Rel siRNA (0.8 mg) or Bcl-X L siRNA (1.2 mg) were condensed with 6 ml RNAiFect Transfection Reagent (Qiagen), for 15 min at room temperature, according to the manufacturer's instructions. To transfect cortical cultures, the transfection complex was diluted in 300 ml of Neurobasal/B27 and added directly to the cells. It was replaced with fresh Neurobasal/B27 3 h later. To transfect SK-N-SH cells, the transfection complex was added in DMEM without serum and antibiotics. It was replaced with complete DMEM 3 h later.
NF-jB activation
Nuclear extract preparation and electrophoretic mobility shift assay (EMSA) Neuronal cultures were exposed to the test drugs for 20 min and to the fresh medium for additional 30 min. Nuclear extracts were prepared as previously described. 27 The protein concentration was assessed by the Bio-Rad Bradford assay according to the manufacturer's instructions. In total, 5 mg of nuclear extracts were combined with 15 fmol of biotin-labelled kB oligonucleotides (APP1, 5 0 -TAGAGACGGGGTTTCACCGTGTTA-3 0 ) in binding buffer using the LightShift Chemilumineshent EMSA kit (Pierce Biotechnology, Rockford, IL, USA) containing poly(dI Á dC) 25 ng/ml and 1 mg bovine serum albumin in a total volume of 20 ml. In competition experiments, 100-fold molar excess of unlabelled competitor oligonucleotides were added together with biotinilated probes. Reactions were carried out for 20 min at room temperature, and protein-DNA complexes were resolved on nondenaturing 4% polyacrylamide gels in 0.5 Â TBE buffer. Gels were then transferred electrophoretically onto a nylon Hybond-N þ membrane (Amersham Biociences, UK). The crosslink of transferred DNA was performed by exposing the membrane to 1.2 J/cm 2 UV light. The biotin-labelled kB DNA was detected according to the manufacturer's instructions. In supershift experiments, nuclear proteins were incubated with antibodies (5 mg) against various NF-kB subunits for 45 min at room temperature. Then, other components of the reaction mixture were added and incubated for an additional 20 min at room temperature. Rabbit polyclonal antibodies against p50, p65 and c-Rel were from Santa Cruz Biotechnology (Germany).
ELISA
Binding of human NF-kB subunits to the NF-kB binding consensus sequence was measured with the ELISA-based Trans-Am NF-kB kit (Active Motif, Carlsbad, CA, USA). The mouse NF-kB subunits were analyzed using the Mercury TransFactor kit (BD Biosciences, Clontech, Palo Alto, CA, USA). The Preparation of cell extracts and analysis procedures were performed as recommended by the manufacturer. Aliquots of nuclear extracts (5 mg) were transferred to 96-well plates containing high-density immobilized kB oligonucleotides. The active forms of either the NF-kB subunits in whole-cell extracts were detected using antibodies specific for the subunit bound to the target DNA. The addition of primary antibody was followed by the addition of an HRP-conjugated secondary antibody. Developing solutions were added and the samples were read by spectrophotometry. The specificity of protein-DNA interaction was checked by measuring the ability of soluble wild-type or mutated oligonucleotides to inhibit the binding. Data are expressed as the difference of absorbance observed in the presence of nuclear extracts and that observed in the absence of nuclear extracts. The ELISA-based analysis of DNA-binding activity of diverse NF-kB factors correlated very well with the EMSA analysis.
Western blot assay
SK-N-SH cells and mouse cortical neuron cells were harvested in 100 ml of lysis buffer (pH 6.9) containing 1 mM methyl sulfonyl fluoride, 1 mg/ml leupeptin, 5 mg/ml aprotinin and 1 mg/ml pepstatin. The suspension was sonicated for 30 s at full power and centrifuged at 21 000 Â g for 30 min at 41C. Total proteins present in the supernatant (25 mg proteins/sample) were suspended in 62.5 mM Tris-HCl, 1% SDS, 5% 2-mercaptoethanol, 10% glycerol and 0.02% bromophenol blue (pH 7.5), and resolved by 10% SDS/polyacrylamide gel. The proteins were transferred electrophoretically onto nitrocellulose membrane. Immunodetection was performed by incubating the membrane O/N at 41C, with the following primary antibodies: polyclonal anti-c-Rel antibody (1 mg/ml, Santa Cruz Biotechnology), polyclonal anti-MnSOD antibody (0.2 mg/ml StressGen Biotechnology Corporation), polyclonal anti-Bcl-X L antibody (4 mg/ml, Santa Cruz Biotechnology), polyclonal anti-mGluR1a antibody (1 mg/ml, Chemicon International, Inc.), polyclonal anti-mGluR5 antiserum specifically recognizing the carboxy-terminal portion mGluR5 (1 : 500), 87 kindly provided by Dr. Rainer Kuhn and anti-b-tubulin antibody (1 : 1500, NeoMarkers). The immunoreaction was revealed by 1 h incubation at 41C with secondary antibodies coupled to horseradish peroxidase (1 : 1500; Santa Cruz Biotechnology) and chemoluminescence detection using ECL Western blotting reagents (Amersham, Italy). Immunoblot of cytochrome c in cytosolic cell extracts was performed with the anticytochrome c monoclonal antibody (sc-13156, 1 : 500, Santa Cruz Biotechnology).
Immunoprecipitation
Co-immunoprecipitation studies were carried out in nuclear extracts from SK-N-SH neuronal cells, either untreated or treated with a CHPG, in RIPA buffer composed of 10 mM tris-HCl pH 8, 140 mM NaCl, 0.5% (v/v) Nonidet P-40, 1 mM sodium orthovanodato, 0.1% SDS, 1 mM phenylmethylsulfonyl fluoride, 1% protease inhibitor cocktail. The antibodies used for immunoprecipitation and immunoblot analysis were: rabbit antip50 (Abcam, Cambridge, Science park Cambridge, UK), goat or rabbit anti-c-Rel (c-Rel-C, Santa Cruz Biotechnology), goat or rabbit anti-p65 (C-20-G, Santa Cruz Biotechnology) and anti-rabbit IgG (Chemicon), as control antiserum. Nuclear extracts (50-100 mg) were incubated at 41C overnight with 2 mg/0.5 ml of corresponding antibodies. After incubation with the antibody, 25 ml of protein A/G (Santa Cruz Biotechnology) was added to the reaction mixture and rotated for 2 h at 41C. Immunoprecipitates were collected by centrifuging at 1000 Â g for 5 min followed by washing four times with RIPA buffers. Following the final wash, all the liquids that adhered to the protein A/G beads were removed. Samples were then resuspended in the sample loading buffer, subjected to SDSpolyacrylamide gel electrophoresis, transferred onto nitrocellulose membrane, and the immunoprecipitated proteins were then detected by Western blotting.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA was extracted from RA-differentiated SK-N-SH cells, using QuickPrep Total RNA extraction kit (Amersham) according to the procedures suggested by the manufacturer. Human thalamic RNA was purchased by BD Clontech (Germany) and used as internal control. Reverse transcriptase reaction was performed using ImProm II TM Reverse transcriptase kit (Promega Corp., USA), according to the manufacturer's instructions using 2 mg of RNA as template and a mixture of antisense oligonucleotides (7.8 mM each) for mGlu1 (5 0 -AGGCCGTCT CATTGGTCTTCA-3 0 ), mGlu5 receptor (5 0 -GGACCATACTTCATCAT CATC-3 0 ) 88 and human b-actin (5 0 -TGATCTTCATTCTGCTGGGTG-3 0 ). For MnSOD and Bcl-X L mRNA analysis, cDNA was synthesized from 2 mg total RNA per sample, using oligo dT primers. PCR was performed in a Perkin-Elmer Model 480 Thermocycler (Emeryville, CA, USA) by incubating 0.2-0.4 mg of the templates with 6.2 mM of specific primers for mGlu1 and mGlu5 receptors, 88 for b-actin (sense 5 0 -GAAGAGCTAC GAGCTGCCTGA-3 0 ; antisense 5 0 -TGATCTTCATTCTGCTGGGTG-3 0 ), 6.6 mM of specific primers for MnSOD (sense 5 0 -GGCGCCCTGGAACCT CACAT-3 0 ; antisense 5 0 -ACACATCAATCCCCAGCAGT-3 0 ) according to Bernard et al., 33 and 7.3 mM of specific primers for Bcl-X L (sense 5 0 -GGATGGCCACTTACCTGA-3 0 ; antisense 5 0 -CGGTTGAAGCGTTCCTG-3 0 ) according to Aerbajinai et al. 89 The templates were heated at 941C for 5 min. In total, 37 (mGlu1, mGlu5) or 35 (MnSOD, Bcl-X L , b-actin) temperature cycles were conducted as follows: denaturation at 941C for 1 min, annealing at 561C (mGlu1, mGlu5, MnSOD, b-actin) or 611C (Bcl-X L ) for 1 min and extension at 721C for 1 min. Additional extension was carried out at 721C for 5 min. PCR products were resolved on 1.2% ethidium bromide-stained agarose gel.
Statistics
Columns in the figures represent means7S.E.M. The cell viability values are means of at least three separate experiments run in triplicate. Statistical significance of the differences was analyzed by Kruskal-Wallis nonparametric ANOVA with adjustment for multiple comparisons.
